Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	90729-43-4
Formula :	C₃₂H₃₉NO₂
M.W :	469.66
SMILES Code :	O=C(C1=CC=C(C(C)(C)C)C=C1)CCCN2CCC(OC(C3=CC=CC=C3)C4=CC=CC=C4)CC2
Synonyms :	LAS-W 090; RP64305; Kestin
MDL No. :	MFCD00865661
InChI Key :	MJJALKDDGIKVBE-UHFFFAOYSA-N
Pubchem ID :	3191

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H413
Precautionary Statements:	P264-P270-P273-P301+P312-P330

U2OS cells	15.505 µM	48 h	Ebastine significantly inhibited the growth of U2OS cells and induced cell cycle arrest and apoptosis.	PMC9830506
MG63 cells	13.254 µM	48 h	Ebastine significantly inhibited the growth of MG63 cells and induced cell cycle arrest and apoptosis.	PMC9830506
MNNG cells	13.635 µM	48 h	Ebastine significantly inhibited the growth of MNNG cells and induced cell cycle arrest and apoptosis.	PMC9830506
Rat isolated heart	605.7 to 383.3 ng·mL⁻¹	130 min	To investigate the pharmacokinetics of ebastine in rat heart, showing that ebastine was metabolized to hydroxyebastine and further to carebastine.	PMC3166699
NIH/3T3 cells	0.01-40 μM	48 h	Evaluate the sensitivity of EBA to normal cells, showing higher sensitivity to TNBC cells than normal cells	PMC10130003
4T1 cells	0-40 μM	24-48 h	Evaluate the effect of EBA on TNBC cell viability, showing concentration-dependent reductions in cell viability	PMC10130003
BT549 cells	0-40 μM	24-48 h	Evaluate the effect of EBA on TNBC cell viability, showing concentration-dependent reductions in cell viability	PMC10130003
MDA-MB-231 cells	0-40 μM	24-48 h	Evaluate the effect of EBA on TNBC cell viability, showing concentration-dependent reductions in cell viability	PMC10130003
HepG2 cells	5 or 10 μM	16 or 24 h	To investigate the effect of ebastine on MKRN1 protein levels, results showed that ebastine decreased MKRN1 protein levels, which was reversed by the proteasome inhibitor MG132.	PMC11785899
LAD2 human mast cells	3 μg/mL	20 h	To study the inhibitory effect of ebastine on MC degranulation, results showed ebastine significantly reduced the induction of inflammatory factors by MC degranulation	PMC11074640

BALB/c nude mice	Subcutaneous transplantation model and lung metastasis model	Oral	0.5 mg/day and 1 mg/day	Once daily for 30/45 days	Ebastine significantly inhibited tumor growth and lung metastasis, with no obvious toxic effects observed.	PMC9830506
Wistar rats	Isolated heart perfusion model	Perfusion	7.8 to 12.1 mg	Single dose, 130 minutes duration	To evaluate the pharmacokinetics and negative inotropic effect of ebastine in rat heart, showing metabolism to hydroxyebastine and carebastine with significant negative inotropic effects.	PMC3166699
Guinea pigs	Arrhythmogenicity model	Oral	20 mg/kg	Single dose, recorded for 4 hours	Evaluate the effect of ketoconazole on Ebastine-induced QTc interval prolongation; results showed Ebastine did not further prolong QTc interval after ketoconazole pretreatment	PMC1915872
BALB/c mice	BCSC-enriched 4T1 allograft model	Intraperitoneal injection	20 mg/kg	Every other day for 34 days	Evaluate the effect of EBA on BCSC-enriched tumor growth, showing significant inhibition of tumor growth and metastasis	PMC10130003
Mice	High-fat-high-fructose diet (HFHFD)-induced MASH model	Intraperitoneal injection	1 and 5 mg/kg	Daily injections for 4 weeks	To investigate the protective effect of ebastine on HFHFD-induced MASH, results showed that ebastine significantly reduced the risk of MASH, with a decrease in MKRN1 expression and an increase in AMPK activity.	PMC11785899
CB17SCID mice	Triple-negative breast cancer (SUM159) xenograft model	Oral	30 mg/kg	5 days per week, for about 28 days	To evaluate the effect of ebastine on tumor growth and progression in triple-negative breast cancer	PMC7541747
C57BL/6N-ACE2em2(hACE2-WPRE, pgk-puro)/CCLA mice	SARS-CoV-2 infection model	Intraperitoneal injection	5 mg/kg	Daily administration, continued until 5 days post-infection	To study the protective effect of ebastine on SARS-CoV-2-induced tracheal injury, results showed ebastine significantly reduced MC degranulation and tracheal injury	PMC11074640

{[proInfo.proName]}

CAS No.: 90729-43-4

{[proInfo.proName]}

CAS No.: 90729-43-4

Alternative Products

Product Details of Ebastine

Safety of Ebastine

Related Pathways of Ebastine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT01144832	Irritable Bowel Syndrome	Phase 4	Completed	-	Belgium ... More >> University hospitals Leuven Leuven, Vlaams-Brabant, Belgium, 3000 Less <<
NCT01940393	Urticaria	Phase 4	Completed	-	Colombia ... More >> Medellin Medellin, Antioquia, Colombia Less <<
NCT02065440	Cough	Not Applicable	Unknown	-	Korea, Republic of ... More >> Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government, Seoul National University Boramae Medical Center Seoul, Dongjak-Gu, Korea, Republic of, 156-707 Less <<
NCT01908465	Irritable Bowel Syndrome (IBS)	Phase 4	Recruiting	March 2018	Belgium ... More >> UZ Antwerpen Not yet recruiting Edegem, Antwerpen, Belgium, 2650 Contact: Tom Moreels, M.D. +32 3 821 33 24 tom.moreels@uza.be Sub-Investigator: Tom Moreels, M.D. ZOL (Ziekenhuis Oost-Limburg) Recruiting Genk, Limburg, Belgium, 3600 Contact: Philip Caenepeel, M.D. +32 8 32 65 13 philip.caenepeel@zol.be Sub-Investigator: Philip Caenepeel, M.D. UZ Gent Recruiting Gent, Oost-Vlaanderen, Belgium, 9000 Contact: Sabine Van de Moortele +32 9 332 68 54 Sabine.VandeMoortele@uzgent.be Contact: Muriël Fouquet +32 9 332 33 36 Muriel.Fouquet@uzgent.be Sub-Investigator: Danny De Looze, M.D. AZ Sint-Elizabeth Zottegem Recruiting Zottegem, Oost-Vlaanderen, Belgium, 9620 Contact: Inge Vanslembrouck, M.D. +32 93 64 83 41 inge.vanslembrouck@sezz.be Contact: Inge Vanslembrouck, M.D. +32 93 64 83 43 inge.vanslembrouck@sezz.be Sub-Investigator: Sebastien Kindt, M.D. UZ Leuven Recruiting Leuven, Vlaams-Brabant, Belgium, 3000 Contact: Lien Beullens, MSc 0032-16-341943 lien.beullens@kuleuven.be Contact: Dafne Balemans 0032-16-330158 dafne.balemans@med.kuleuven.be Principal Investigator: Guy Boeckxstaens, M.D. AZ Sint-Lucas Brugge Recruiting Brugge, West-Vlaanderen, Belgium, 8310 Contact: Hilde Nevens +32 50 36 57 11 hilde.nevens@stlucas.be Contact: Joris Arts, M.D. +32 50 36 51 55 jar@stlucas.be Sub-Investigator: Joris Arts, M.D. Netherlands Rijnstate Not yet recruiting Arnhem, Gelderland, Netherlands, 6800 Contact: B.G. Baten, M.D. 0031 88 005 6671 Contact: D. Hirsch, M.D. DHirsch@Rijnstate.nl Sub-Investigator: D. Hirsch, M.D. Medisch Spectrum Twente Not yet recruiting Enschede, Limburg, Netherlands, 7500 Contact: Anita Westerhof 0031(53)4877511 Contact: J. Kolkman, M.D. 0031 (53) 487 24 10 j.kolkman@mst.nll Sub-Investigator: J. Kolkman, M.D. AZ Maastricht Not yet recruiting Maastricht, Limburg, Netherlands, 6202 Contact: Samefko Ludidi Contact: A. Masclee, M.D. a.masclee@mumc.nl Sub-Investigator: A. Masclee Sint Lucas Andreas Ziekenhuis Not yet recruiting Amsterdam, Noord-Holland, Netherlands, 1061 Contact: Sjoerd Kuiken, M.D. s.kuiken@slaz.nl Sub-Investigator: Sjoerd Kuiken, M.D. Academisch Medisch Centrum Not yet recruiting Amsterdam, Noord-Holland, Netherlands, 1105 Contact: A.J. Bredenoord, M.D. A.J.Bredenoord@amc.uva.nl Sub-Investigator: A.J. Bredenoord, M.D. Tergooiziekenuizen Blaricum/Hilversum Not yet recruiting Hilversum/Blaricum, Noord-Holland, Netherlands, 1213/1261 Contact: Karen Verloop 0031 (35) 539 19 25 kverloop@tergooiziekenhuizen.nl Contact: B. van den Elzen, M.D. BvandenElzen@tergooiziekenhuizen.nl Sub-Investigator: B. van den Elzen, M.D. Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed